Skip to main content
Clinical Trials/NCT03045224
NCT03045224
Completed
Not Applicable

Endovascular Treatment in Patients With Peripheral Artery Disease: Real Life Effectiveness Off the Road of Studies PTA-Registry, a Prospective, Multicenter Study With 24-Month Follow-up

Vascular Center Berlin0 sites1,760 target enrollmentAugust 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Efficacy/Long-term Effectiveness Endovascular Therapy in PAD
Sponsor
Vascular Center Berlin
Enrollment
1760
Primary Endpoint
death of any cause
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The PTA-Registry (PTA-REG) is a prospective health services research registry to monitor and follow-up patients with peripheral arterial disease undergoing endovascular peripheral intervention. The PTA-REG has an interdisciplinary approach: cardiologists, angiologists, and radiologists contributed actively to this registry.

Detailed Description

The registry was created for the following purposes: evaluation of the clinical effectiveness, safety and quality of the endovascular therapy, and history of the disease after endovascular therapy. The resulting specific research questions were determination of the technical and clinical success of the procedure, monitoring of periinterventional complications, evaluation of vessel patency, amputation rate, mortality, and major adverse cardiac events during the follow-up. In addition, the quality of life after endovascular peripheral intervention over a period of two years was evaluated.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
September 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Vascular Center Berlin
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. K.-L. Schulte

Head of Vascular Center Berlin

Vascular Center Berlin

Eligibility Criteria

Inclusion Criteria

  • peripheral arterial disease of the iliac and lower extremity arteries and appropriate clinical indication for treatment with PTA according to current guidelines

Exclusion Criteria

  • no exclusion criteria and no age restriction

Outcomes

Primary Outcomes

death of any cause

Time Frame: 2 years

revascularization (TLR, TVR)

Time Frame: 2 years

Secondary Outcomes

  • minor or major amputation(2 years)
  • major adverse cardiac events and stroke(2 years)
  • quality of life(2 years)

Similar Trials